TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
AVIR

Atea Pharmaceuticals Inc

Healthcare · Biotechnology

5.20$ +0.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement AVIR
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– – – +622.5% -45.3% -100.0% – –
– +0.0% +223,564.7% -99.9% +796.6% +26,857.7% +18.9% -99.5%
– – – +3,211.7% -100.1% – – –
– +52.4% +273.9% +339.7% -51.0% +62.1% +9.5% +1.8%
– +58.4% +387.6% +111.6% +6.4% +2.5% -2.1% -32.7%
– +54.1% +48.1% +884.2% -38.7% -28.0% +16.5% +65.1%
– – – – -194.4% – – –
– – – +191.6% +4,507.9% – – –
– – – – -186.2% – – –
– -239.0% – – -120.6% – -9.1% -766.2%
– – – – -195.6% – – –
– – – – -194.2% – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?